Global CRO MarketTransformation, developments, opportunities and future of CRO market
P846-52 February 2015
2P846-52
Table of Contents
Section Slide Numbers
Executive Summary 5
Market Overview 21
Competitive Playbook 34
Total CRO Market -
• External Challenges: Drivers and Restraints 44
• Forecast and Trends –Total Market 51
Competitive Environment 61
CRO Segment Analysis -
• Pre-clinical Trials Segment 75
• Phase I Trials Segment 83
• Phase II Trials Segment 92
• Phase III Trials Segment 99
• Phase IV Trials Segment 107
3P846-52
Section Slide Numbers
• Data Management Segment 115
• Biostatistics Segment 123
• Pharmacovigilance Segment 131
• Health Economics & Outcomes Research (HEOR) Segment 139
• Pharmaceuticals and Biotech Laboratory Testing Services Segment 147
o Analytical Testing Services -
• cGMP Testing Segment 154
• Bio-analytical Testing Segment 162
o Analytical Testing Services Segment Competitive Environment 170
o Central Laboratory Testing Segment 181
Table of Contents (continued)
4P846-52
Section Slide Numbers
Regional Breakdown -
• North America CRO Market Overview 188
• North America Segment Analysis by Phases 196
• Europe CRO Market Overview 205
• Europe Segment Analysis by Phases 212
• APAC CRO Market Overview 220
• APAC Segment Analysis by Phases 228
• Rest of the World (ROW) CRO Market Overview 236
• Rest of the World (ROW) Segment Analysis by Phases 244
The Last Word 252
Appendix 256
Table of Contents (continued)
5P846-52
Market Size Estimation Methodology
Frost & Sullivan followed a three-step methodology to develop the analysis:
The information above was analysed and aggregated to produce this research service.
Frost & Sullivan uses the expertise of the global research staff
supported by the internal databases to develop insights into the
contract research market.
Secondary research is utilised to develop a baseline understanding of
the contract research industries as well as to identify key stakeholders
for the primary research phase.
Approximately 80 percent to 90 percent of the data provided in the
primary research is focused on obtaining targeted information from key
market participants by means of telephone and face to face interviews.
2. Secondary Research
3. Primary Research
1. Internal Expertise
Source: Frost & Sullivan
6P846-52
Scope and Segmentation
Scope
Geographic coverage Global
Study period 2013–2019
Base year 2014
Forecast period 2014–2019
Monetary unit US Dollars
Geographical Segmentations:
• North America
• Europe
• APAC
• ROW
This research service analyses the global clinical trials and research outsourcing (CRO) market.
It provides revenue forecasts for CROs globally by phase, therapeutic type and region.
The research study addresses the major issues and challenges, unmet needs and emerging trends in the market. Also, outlines market drivers and restraints and R&D trends.
Source: Frost & Sullivan
7P846-52
Key Questions This Study Will Answer
How will contract research outsourcing help in drug development by saving time and cost for manufacturers?
What is the impact of the market growth in different regions?
Who are the predominant market participants in the CRO market and their market share contribution?
What are the key market trends observed towards expansion of contract research organizations in drug development across key therapeutic areas?
Are the products/services offered today meeting customer needs or is additional development needed?
What are the key market segments to look out for and what are the key trends followed in the market?
Source: Frost & Sullivan
8P846-52
Segmentation: CRO Value Chain
Source: Frost & Sullivan
Pre-clinical
Product Development Approval
Health Economic and outcome research (HEOR)
Phase I Phase II Phase III Phase IV
Central Lab
Biostatistics
Data Management
Late PhaseInterventional
Late PhaseObservational
Late Phase Pharmacovigilance
Other HealthcareSolutions
Commercialization
Bio-analytical TestingBio-analytical Testing
Total CRO Market: Stages of Clinical Development, Global, 2014
9P846-52
Pharmaceuticals and Biotech Laboratory Testing Services: Market Overview
Discovery Preclinical Phase 1 Phase 2 Phase 3 Phase 4 Market
Bio-analytical Testing
cGMP Testing
Central Laboratory Testing
Key Companies: Eurofins Scientific, PPD, Quintiles, Covance,
LabCorp, ICON
Key Companies: Eurofins Scientific, WuXi AppTec, SGS Life
Sciences, Bio Reliance, etc
Key Companies: Charles River Laboratory, Eurofins Scientific, Bio-
Reliance, WuXi AppTec, SGS Life Sciences, PPD
Core activity in Drug Development
Non-core activity in Drug Development
Pharmaceuticals and Biotech Laboratory Testing Services : Market Overview, Global, 2014
Pharmaceutical Laboratory Testing Market
Source: Company Presentation, Frost & Sullivan
10P846-52
The Pharmaceutical Laboratory Testing outsourcing market comprises the following service segments:
1. cGMP Analytical Testing: QC Testing (Release, Environmental, Microbiology testing) Services, Purity, Safety and Characterization Services, Formulation & Stability and Storage Services, Package and Container Testing Services
2. Bio-Analytical Testing: Biomarker Testing, Cell-Based Assays, Immunogenicity & Neutralizing Antibody, Metabolite Profiling & Balance Studies (14C-Labeled Drug), Method Development Optimization & Validation, Pharmacokinetic Testing
3. Central Laboratories
Analytical Testing
Total Pharmaceuticals and Biotech Laboratory Testing Service Market
Pharmaceuticals and Biotech Laboratory Testing Services: Market Segmentation, Global, 2014
Bio Analytical
Testing
Pharmaceuticals and Biotech Laboratory Services Market Segmentation
Central Labs
cGMP Analytical
Testing
Source: Frost & Sullivan
11P846-52
Rise in demand for conducting global trials
IT-enabled offerings to
grow
Data analytics to witness
radical growth
Increased strategic M&A
Speed time-to-market
Cost effective advance
innovation
Increase in laboratory
testing outsourcing
Demand for late-stage
development services
One stop shop for
laboratory services
Global CRO Key Market Trends
For detailed version, click here.
Source: Frost & Sullivan
12P846-52
CEO’s Perspective
2
Rising competition from developing countries such as Asian and Latin American countries are impeding the market growth of developed nations
3Outsourcing in early phases of clinical trials will rise, as big pharmaceutical companies are exploring this as a cost saving measure
4Increased flexibility in services provided by CROs, especially in the function-to-function outsourcing model
5
Strengthening of outsourcing partnerships and alliances with leading pharmaceutical and biotech companies through improved strategic long-term contracts.
1
Adopting a forward looking business model to efficiently address the growing needs of the CRO industry. A model with constant improvisations in managing clinical trials
Source: Frost & Sullivan
13P846-52
Sample of Key Highlights
• The global CRO market was xxxx billion in 2014 and is expected to reach xxx x billion in 2019,
growing at a robust CAGR of xx from 2013 to 2019.
• The penetration of global CRO market stood at xx in 2014 against the potential outsourcing market
providing a huge opportunity for CRO companies to increase their market share.
• The share of services, such as Data management, Biostatistics, Health economic outcome
research and Labs is expected to grow at a double digit rate in next 5-6 years.
• Geographic outsourcing to lower-cost locations is likely to result in lesser margins in the short term,
but increased volume share. However, with increased capacity and scale, companies are expected
to improve their margins during rest of the forecast period.
• The volume of outsourcing to emerging markets is expected to increase significantly. However,
North America will retain a large portion of the high-value business.
• Specialized services such as eClinical trial solutions, adaptive trial designs and outcomes research
are expected to transform the way clinical trials are performed today.
Source: Frost & Sullivan analysis.
14P846-52
Partial List of Companies Interviewed
• CMIC Co. Ltd
• Covance, Inc.
• InVentiv health
• INC Research
• LSK Global Pharma Service
• Novotech (Australia) Pty Ltd
• PAREXEL International
• Pharmaceutical Product Development
(PPD)
• PhaseON Clinical Research Pvt. Ltd
• PRA International
Source: Frost & Sullivan research.
• QUANTICATE LTD
• Quintiles
• SGS Life Sciences
• Tigermed Consulting Ltd.
• WuXi PharmaTech